0003-1614 : Baraclude .05 mg/ml Oral Solution
| NDC: | 0003-1614 |
| Labeler: | E.r. Squibb & Sons, L.L.C. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Baraclude |
| Dosage Form: | Oral Solution |
| Application #: | NDA021798 |
| Rev. Date: |
NDC Package Codes:
- 0003-1614-12: 1 BOTTLE IN 1 CARTON (0003‑1614‑12) > 210 ML IN 1 BOTTLE
Active Ingredients:
- Entecavir
Dosage Strength:
- .05 mg/mL
Pharmaceutical Classes:
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Nucleoside Analog [EXT]
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0003-1611 Baraclude 0.5 mg Oral Tablet by E.r. Squibb & Sons, L.L.C.
- 0003-1612 Baraclude 1 mg Oral Tablet by E.r. Squibb & Sons, L.L.C.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0003-1612Next: 0003-1964 >
Related Discussions:
LN beta 2.5 mg and Baraclude (Entecavir)
My mother (age 50) has hepatitis B. She is on Baraclude (Entecavir). Recently she was diagnosed with high blood pressure... 1 reply
My mother (age 50) has hepatitis B. She is on Baraclude (Entecavir). Recently she was diagnosed with high blood pressure... 1 reply
Baraclude for liver cirrhosis
My brother-in-law has been sufferring from liver cirrhosis for the past two months. Is baraclude used for liver cirrhosi... 1 reply
My brother-in-law has been sufferring from liver cirrhosis for the past two months. Is baraclude used for liver cirrhosi... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.